Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.000
-0.270 (-11.89%)
At close: Jun 26, 2026, 4:00 PM EDT
2.100
+0.100 (5.00%)
After-hours: Jun 26, 2026, 7:44 PM EDT
Nautilus Biotechnology Employees
Nautilus Biotechnology had 127 employees as of March 31, 2026. The number of employees decreased by 3 or -2.31% since the number was last reported on December 31, 2025.
Employees
127
Change
-3
Growth
-2.31%
Revenue / Employee
n/a
Profits / Employee
-$449,488
Market Cap
254.16M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fate Therapeutics | 161 |
| Lyell Immunopharma | 161 |
| AC Immune | 122 |
| Invivyd | 122 |
| Niagen Bioscience | 117 |
| Foghorn Therapeutics | 106 |
| Orchestra BioMed Holdings | 86 |
| Armata Pharmaceuticals | 61 |
NAUT News
- 10 days ago - Nautilus Biotechnology Transcript: AGM 2026 - Transcripts
- 2 months ago - Nautilus Biotechnology Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Nautilus Biotechnology Earnings release: Q1 2026 - Filings
- 2 months ago - Nautilus Biotechnology Quarterly report: Q1 2026 - Filings
- 2 months ago - Nautilus Biotechnology Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 2 months ago - Nautilus Biotechnology Proxy statement: Proxy filing - Filings
- 2 months ago - Nautilus Biotechnology Proxy statement: Proxy filing - Filings
- 3 months ago - Nautilus Biotechnology Transcript: Investor Summit Virtual Conference - Transcripts